Novartis

[video]Did Novartis Overpay for AveXis?
Motley Fool
Mon, 04/16/18 - 11:34 pm
Novartis
AveXis
gene therapy
M&A
Q1 kicks off with J&J, Novartis, Glaxo results
Biopharma Dive
Sun, 04/15/18 - 09:48 pm
earnings
JNJ
Novartis
GSK
3 Biotech Stocks That Soared This Week
Motley Fool
Sat, 04/14/18 - 12:37 pm
AveXis
Abeona Therapeutics
Spectrum Pharmaceuticals
Novartis
M&A
poziotinib
EB-101
Novartis CEO: How To Create Cheaper Alternatives To The Most Expensive Drugs
Forbes
Thu, 04/12/18 - 11:49 am
Novartis
Pharma CEOs
FDA
drug pricing
Vasant Narasimham
Novartis offloads failed cancer drug to Oncology Venture
Fierce Biotech
Wed, 04/11/18 - 09:32 am
Novartis
Oncology Venture
dovitinib
kidney cancer
cancer
Physician payments linked to scripts for cancer drugs from Novartis, Pfizer and more: study
Fierce Pharma
Tue, 04/10/18 - 10:30 pm
physician payments
Novartis
Pfizer
Bayer
Bristol-Myers Squibb
cancer
Why Did Novartis Spend $9 Billion On Gene Therapy? CEO Says: 'A Journey To Focus On Data And Digital'
Forbes
Mon, 04/9/18 - 03:31 pm
Novartis
Vas Narasimhan
M&A
gene therapy
AveXis
Biogen faces increased 'pressure' after AveXis buyout by Novartis
Marketwatch
Mon, 04/9/18 - 09:10 am
Novartis
AveXis
Biogen
SMA
M&A
AVXS-1-1
Spinraza
Novartis buying AveXis for $8.7 billion to strengthen gene therapy capabilities
Stat
Mon, 04/9/18 - 09:00 am
Novartis
M&A
AveXis
gene therapy
AVXS-101
SMA
spinal muscular atrophy
Novartis, still embroiled in Greek probe, faces kickback allegation in China—again
Fierce Pharma
Fri, 04/6/18 - 11:24 am
Novartis
China
Greece
kickbacks
bribery
Conatus Pharma’s Liver Disease Drug Flunks First Phase 2 Test
Xconomy
Thu, 04/5/18 - 11:57 pm
Conatus Pharmaceuticals
clinical trials
Novartis
emricasan
liver disease
hepatitis C
Novartis Likely Delayed In Launching Copycat Of Amgen Blockbuster
Investors Business Daily
Fri, 03/30/18 - 09:26 am
Novartis
Amgen
Enbrel
biosimilars
Novartis sues Regeneron over manufacturing methods
Biopharma Dive
Thu, 03/29/18 - 09:14 pm
Novartis
Regeneron
drug manufacturing
Zaltrap
Eylea
GSK buys out Novartis in $13 billion consumer healthcare shake-up
Yahoo/Reuters
Tue, 03/27/18 - 09:56 am
GSK
Novartis
consumer healthcare
M&A
Pharma's social media strategies are growing up—and working better, too, report finds
Fierce Pharma
Mon, 03/26/18 - 09:34 am
social media
Novo Nordisk
JNJ
Novartis
Boehringer Ingelheim
Novartis' Siponimod significantly improved outcomes in PhIII data published in Lancet
CP Wire
Fri, 03/23/18 - 12:55 am
Novartis
siponimod
clinical trials
MS
multiple sclerosis
SPMS
12 blockbusters: The surging list of $1B-plus drugs rolling out on the market this year might surprise you
Endpoints
Thu, 03/22/18 - 09:21 am
drug launches
Hemlibra
Roche
Biktarvy
Gilead Sciences
Ozempic
Novo Nordisk
Erleada
JNJ
Shingrix
GSK
Patisiran
Alnylam
Sanofi
Epidiolex
GW Pharma
Aimovig
Amgen
Novartis
lanadelumab
Shire
Elagolix
AbbVie
Steglatro
Pfizer
Merck
Sublocade
Indivior
Novartis, Harvard team up to develop immunotherapy drug-delivery systems
Drug Delivery Business News
Thu, 03/22/18 - 09:03 am
Novartis
Harvard
immunotherapy
drug delivery
R&D
immuno-oncology
Novartis sales rep said that reps were “essentially buying scripts” as seven-year old case moves to trial
Bloomberg
Wed, 03/21/18 - 09:13 am
Novartis
drug reps
physicians
physician payments
Drug companies are beginning to wake up to this new risk factor
Marketwatch
Mon, 03/19/18 - 12:05 pm
pharma industry
co-pay coupons
Pfizer
Sanofi
Amgen
Novartis

Pages